A BEAT-PCD consensus statement : a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia
Copyright ©The authors 2024..
Background: Consistent use of reliable and clinically appropriate outcome measures is a priority for clinical trials, with clear definitions to allow comparability. We aimed to develop a core outcome set (COS) for pulmonary disease interventions in primary ciliary dyskinesia (PCD).
Methods: A multidisciplinary international PCD expert panel was set up. A list of outcomes was created based on published literature. Using a modified three-round e-Delphi technique, the panel was asked to decide on relevant end-points related to pulmonary disease interventions and how they should be reported. First, inclusion of an outcome in the COS was determined. Second, the minimum information that should be reported per outcome. The third round finalised statements. Consensus was defined as ≥80% agreement among experts.
Results: During the first round, experts reached consensus on four out of 24 outcomes to be included in the COS. Five additional outcomes were discussed in subsequent rounds for their use in different subsettings. Consensus on standardised methods of reporting for the COS was reached. Spirometry, health-related quality-of-life scores, microbiology and exacerbations were included in the final COS.
Conclusion: This expert consensus resulted in a COS for clinical trials on pulmonary health among people with PCD.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
ERJ open research - 10(2024), 1 vom: 01. Jan. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kos, Renate [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 11.01.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1183/23120541.00115-2023 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366874977 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366874977 | ||
| 003 | DE-627 | ||
| 005 | 20240114233946.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1183/23120541.00115-2023 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1256.xml |
| 035 | |a (DE-627)NLM366874977 | ||
| 035 | |a (NLM)38196895 | ||
| 035 | |a (PII)00115-2023 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kos, Renate |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A BEAT-PCD consensus statement |b a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 11.01.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright ©The authors 2024. | ||
| 520 | |a Background: Consistent use of reliable and clinically appropriate outcome measures is a priority for clinical trials, with clear definitions to allow comparability. We aimed to develop a core outcome set (COS) for pulmonary disease interventions in primary ciliary dyskinesia (PCD) | ||
| 520 | |a Methods: A multidisciplinary international PCD expert panel was set up. A list of outcomes was created based on published literature. Using a modified three-round e-Delphi technique, the panel was asked to decide on relevant end-points related to pulmonary disease interventions and how they should be reported. First, inclusion of an outcome in the COS was determined. Second, the minimum information that should be reported per outcome. The third round finalised statements. Consensus was defined as ≥80% agreement among experts | ||
| 520 | |a Results: During the first round, experts reached consensus on four out of 24 outcomes to be included in the COS. Five additional outcomes were discussed in subsequent rounds for their use in different subsettings. Consensus on standardised methods of reporting for the COS was reached. Spirometry, health-related quality-of-life scores, microbiology and exacerbations were included in the final COS | ||
| 520 | |a Conclusion: This expert consensus resulted in a COS for clinical trials on pulmonary health among people with PCD | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Goutaki, Myrofora |e verfasserin |4 aut | |
| 700 | 1 | |a Kobbernagel, Helene E |e verfasserin |4 aut | |
| 700 | 1 | |a Rubbo, Bruna |e verfasserin |4 aut | |
| 700 | 1 | |a Shoemark, Amelia |e verfasserin |4 aut | |
| 700 | 1 | |a Aliberti, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Altenburg, Josje |e verfasserin |4 aut | |
| 700 | 1 | |a Anagnostopoulou, Pinelopi |e verfasserin |4 aut | |
| 700 | 1 | |a Athanazio, Rodrigo A |e verfasserin |4 aut | |
| 700 | 1 | |a Beydon, Nicole |e verfasserin |4 aut | |
| 700 | 1 | |a Dell, Sharon D |e verfasserin |4 aut | |
| 700 | 1 | |a Emiralioglu, Nagehan |e verfasserin |4 aut | |
| 700 | 1 | |a Ferkol, Thomas W |e verfasserin |4 aut | |
| 700 | 1 | |a Loebinger, Michael R |e verfasserin |4 aut | |
| 700 | 1 | |a Lorent, Natalie |e verfasserin |4 aut | |
| 700 | 1 | |a Maître, Bernard |e verfasserin |4 aut | |
| 700 | 1 | |a Marthin, June |e verfasserin |4 aut | |
| 700 | 1 | |a Morgan, Lucy C |e verfasserin |4 aut | |
| 700 | 1 | |a Nielsen, Kim G |e verfasserin |4 aut | |
| 700 | 1 | |a Ringshausen, Felix C |e verfasserin |4 aut | |
| 700 | 1 | |a Shteinberg, Michal |e verfasserin |4 aut | |
| 700 | 1 | |a Tiddens, Harm A W M |e verfasserin |4 aut | |
| 700 | 1 | |a Maitland-Van der Zee, Anke H |e verfasserin |4 aut | |
| 700 | 1 | |a Chalmers, James D |e verfasserin |4 aut | |
| 700 | 1 | |a Lucas, Jane S A |e verfasserin |4 aut | |
| 700 | 1 | |a Haarman, Eric G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ERJ open research |d 2015 |g 10(2024), 1 vom: 01. Jan. |w (DE-627)NLM255762003 |x 2312-0541 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2024 |g number:1 |g day:01 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1183/23120541.00115-2023 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2024 |e 1 |b 01 |c 01 | ||